Great work value adding to AHZ's adapt process.
Its good to see new products driven by demand entering the market.
The history of cardiocel take up and many posts here by those with medical knowledge have highlighted the fact that adoption by doctors of new stuff is a softly slowly process.
Hopefully those that have had the experience with the cardiocel patch should have the confidence to accelerate the take up of this new patch.
Some of the product it displaces will also be our own.
CardioCel Neo has arrived., page-16
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |